Reaction
Histoplasmosis reporting signals
As of the last recalculation, Histoplasmosis appears in 1,751 FAERS reports alongside 36 co-occurring drug terms. The strongest observed disproportionality signal is ITRACONAZOLE (PRR 120.6).
Important: FAERS is a spontaneous, voluntary, unverified reporting system. PRR and ROR identify reporting patterns for investigation; they are not incidence rates and do not establish causation.
| Drug | Co-reports | PRR | ROR |
|---|---|---|---|
| Itraconazole | 111 | 120.6 | 121.7 |
| Amphotericin B | 40 | 38.8 | 38.9 |
| Mycophenilic Acid | 55 | 32.5 | 32.6 |
| Efavirenz | 30 | 32.5 | 32.6 |
| Infliximab | 382 | 26.3 | 26.4 |
| Tacrolimus Ointment 0.1% | 233 | 25.5 | 25.5 |
| Tacrolimus Extended-Release Capsules | 233 | 25.4 | 25.5 |
| Lamivudine Oral | 51 | 24.7 | 24.7 |
| Mycophenolate Mofetil | 235 | 23.6 | 23.6 |
| Mycophenolate Mofetil Hydrochloride | 235 | 23.6 | 23.6 |
| Tacrolimus | 264 | 23.4 | 23.5 |
| Mycophenolic Acid | 60 | 23.0 | 23.1 |
| Mercaptopurine | 30 | 20.9 | 20.9 |
| Lamivudine | 52 | 20.6 | 20.6 |
| Zidovudine | 21 | 18.9 | 18.9 |
| Atovaquone | 12 | 17.8 | 17.9 |
| Abacavir Sulfate | 14 | 17.2 | 17.2 |
| Basiliximab | 16 | 16.3 | 16.3 |
| Azathioprine | 90 | 12.7 | 12.8 |
| Prednisone | 408 | 12.3 | 12.3 |
| Calcium Gluconate | 12 | 11.9 | 11.9 |
| Adalimumab-Fkjp | 45 | 11.8 | 11.8 |
| Adalimumab-Aaty | 45 | 11.6 | 11.6 |
| Icosapent Ethyl | 8 | 11.2 | 11.2 |
| Adalimumab-Adaz | 48 | 11.1 | 11.1 |
| Voriconazole Injection | 20 | 11.1 | 11.1 |
| Anti-Thymocyte Globulin (Rabbit) | 7 | 10.4 | 10.4 |
| Voriconazole | 21 | 8.3 | 8.3 |
| Tenofovir Disoproxil Fumarate Tablets | 6 | 8.3 | 8.3 |
| Ganciclovir | 7 | 8.2 | 8.2 |
| Anakinra | 11 | 7.9 | 7.9 |
| Ganciclovir Sodium | 7 | 7.9 | 7.9 |
| Hydroxychloroquine | 47 | 7.7 | 7.7 |
| Tofacitinib Citrate | 8 | 7.3 | 7.3 |
| Azacitidine For | 6 | 3.9 | 3.9 |
| Daratumumab | 11 | 3.3 | 3.3 |